International Congress on Targeting Ebola
نویسندگان
چکیده
The International Congress on Targeting Ebola 2015 was held on 28–29 May 2015 at the Pasteur Institute in Paris (www.targetingebola.com). The meeting was organised in partnership with the COPED of the French Academy of Sciences, the French Task Force Group for Ebola, the Pasteur Institute and the Task Force for Infectious Diseases. Publication of a summary of the meeting by the organisers is anticipated in an open-access journal. This paper aims to provide a brief overview of the main discussion points during the meeting.
منابع مشابه
A review on West African Ebola epidemic dynamics models
Background and aims: The world is threatened by disease outbreak that reaches a public health emergency of international concern, studies to inform public and agencies for effective containment strategy are necessary. Several studies provided vital information of the dynamics and control of Ebola epidemic outbreak in West Africa. Methodologies and techniques in those researches...
متن کاملObama calls on Congress to fund $6.2bn emergency Ebola initiative.
At a speech given on 2 December at the US National Institutes of Health, President Barack Obama called on Congress to pass his $6.2bn (£4bn; €5bn) funding request for emergency Ebola programs before its recess for the holiday period. “For the most part, people have recognized this is not a Democratic issue or a Republican issue—it’s about the safety and security of the American people. So let’s...
متن کاملRepurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic review
BACKGROUND The recent Ebola epidemic in western Africa developed into an acute public health emergency of unprecedented level in modern times. The treatment provided in most cases has been limited to supportive care, as no approved therapies are available to date. Several established, licenced drugs have been suggested as potential repurposed therapeutic agents for Ebola. However, scientific da...
متن کاملEffective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions
Ebola virus is responsible for causing severe hemorrhagic fevers, with case fatality rates of up to 90%. Currently, no antiviral or vaccine is licensed against Ebola virus. A phosphatidylserine-targeting antibody (PGN401, bavituximab) has previously been shown to have broad-spectrum antiviral activity. Here, we demonstrate that PGN401 specifically binds to Ebola virus and recognizes infected ce...
متن کامل